Sign In
Buy GMAB
$23.88
+0.0300 (+0.126%)
At Close: Jun 03, 2026
What 4 Analyst Ratings Have To Say About Genmab
09:01pm, Wednesday, 01'st Mar 2023 Benzinga
Genmab (NASDAQ:GMAB) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
0
1
3
0
Last 30D
0
0
0
Genmab A/S (GMAB) Q4 2022 Earnings Call Transcript
03:34pm, Wednesday, 22'nd Feb 2023
Genmab A/S (GMAB) Q4 2022 Results Conference Call February 22, 2023 12:00 PM ET Company Participants Jan van de Winkel - President and Chief Executive Officer Anthony Pagano - Chief Financial Officer
Zacks.com featured highlights Genmab, Hologic, ServiceNow and Splunk
10:00am, Thursday, 09'th Feb 2023 Zacks Investment Research
Genmab, Hologic, ServiceNow and Splunk have been highlighted in this Screen of The Week article.
4 Top Stocks to Buy on Earnings Beat Potential
01:03pm, Wednesday, 08'th Feb 2023 Zacks Investment Research
These top-ranked stocks are likely to beat on the bottom line in their next releases. These stocks include Genmab (GMAB), Hologic (HOLX), ServiceNow (NOW) and Splunk (SPLK).
4 Top Stocks to Buy on Earnings Beat Potential
09:47am, Wednesday, 08'th Feb 2023
These top-ranked stocks are likely to beat on the bottom line in their next releases. These stocks include Genmab (GMAB), Hologic (HOLX), ServiceNow (NOW) and Splunk (SPLK).
Genmab: High-Quality Biotech Darling, But Lacks Meaningful Catalysts In The Near Term
06:48am, Tuesday, 31'st Jan 2023
Genmab (GMAB) is a Danish commercial biopharma company with a leading technology and track record in innovative antibody-based therapeutics. Darzalex royalty revenue is the key driver of the stock pri
GILD or GMAB: Which Is the Better Value Stock Right Now?
04:40pm, Monday, 23'rd Jan 2023 Zacks Investment Research
GILD vs. GMAB: Which Stock Is the Better Value Option?
GILD or GMAB: Which Is the Better Value Stock Right Now?
12:48pm, Monday, 23'rd Jan 2023
GILD vs. GMAB: Which Stock Is the Better Value Option?
New Strong Buy Stocks for January 11th
01:13pm, Wednesday, 11'th Jan 2023 Zacks Investment Research
GMAB, OSW, ACDC, EVBG and MTG have been added to the Zacks Rank #1 (Strong Buy) List on January 11 , 2023.
New Strong Buy Stocks for January 11th
09:47am, Wednesday, 11'th Jan 2023
GMAB, OSW, ACDC, EVBG and MTG have been added to the Zacks Rank #1 (Strong Buy) List on January 11 , 2023.
3 Biotech Companies to Watch in 2023
06:50pm, Friday, 06'th Jan 2023
Biotech stocks are in high demand right now, with good reason. Indeed, these biotech companies have the potential to revolutionize the medical world and offer solutions to unmet needs, while their rel
100 Best Stocks Of 2022: Oil Stocks And Medicals Shine
06:00pm, Friday, 30'th Dec 2022
Medical and energy companies, including oil stocks, lead the list of the 100 best stocks in 2022. The post 100 Best Stocks Of 2022: Oil Stocks And Medicals Shine appeared first on Investor's Business
Biotech And Medical Stocks Leading Performers As 2022 Draws To A Close
03:49pm, Friday, 23'rd Dec 2022
These leading biotech stocks have had a good quarter and some may have room to run, while for others it's time to ring the register. The post Biotech And Medical Stocks Leading Performers As 2022 Draw
With Bear Market Scars, These 26 Stocks Expect Up To 1,220% Growth
01:08pm, Wednesday, 21'st Dec 2022
Oil stocks dominate this list of today's fastest-growing stocks, all eyeing 100%-1,220% EPS gains this year. The post With Bear Market Scars, These 26 Stocks Expect Up To 1,220% Growth appeared first
Ensign Group (ENSG) Unveils Dividend Hike to Reward Shareholders
06:49pm, Monday, 19'th Dec 2022 Zacks Investment Research
Ensign Group's (ENSG) latest dividend hike reflects strong financial standing and intensified focus in the tactical deployment of capital.
